Related Experiment Video
Updated: Jul 11, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Predictors for non-attainment of meropenem target concentrations when treating infections in critically ill patients
Background:
Failure to achieve target concentrations of β-lactam antibiotics is not uncommon despite administration of high doses. The objective of this study was to identify risk factors predicting non-attainment of β-lactams target concentration in critically ill patients receiving meropenem as an intravenous infusion.
Materials And Methods:
The retrospective study included adult patients receiving meropenem by intravenous infusion and undergoing therapeutic drug monitoring (TDM) in the intensive care units (ICU) at Nanjing First Hospital. Blood samples were analyzed using UPLC-MS. Potential risk factors were evaluated by correlating them with meropenem trough concentrations (Cmin) lower than the targeted concentration (the minimum inhibitory concentration (MIC)).
Results:
Non-attainment of target concentrations was observed in 41 patients (19.5%) of the 210 patients examined. Predictors for non-attainment using multivariate logistic regression analysis were: age (p = 0.013), dosage (p = 0.042), augmented renal clearance (ARC), (p = 0.041).
Conclusion:
In addition to the expected risk factors (age and dosage), ARC was a predictor for non-attainment of the target concentration. The risk of non-attainment of target concentrations increased with an increase in creatinine clearance. Attention should be given to ARC and creatinine clearance when administering meropenem by intravenous infusion.
Insights
Augmented renal clearance (ARC) is a key factor in achieving target meropenem concentrations in critically ill patients. Increased creatinine clearance raises the risk of sub-therapeutic levels, necessitating careful monitoring.
Area of Science:
- Pharmacokinetics and Pharmacodynamics
- Critical Care Medicine
- Infectious Diseases
Background:
- Sub-therapeutic beta-lactam antibiotic concentrations are common in critically ill patients.
- High doses of meropenem may not achieve target concentrations.
- Identifying risk factors for non-attainment is crucial for optimizing therapy.
Purpose of the Study:
- To identify risk factors for failing to reach target meropenem concentrations.
- To investigate predictors of sub-therapeutic meropenem levels in intensive care unit (ICU) patients.
- To inform dosing strategies for meropenem in critically ill populations.
Main Methods:
- Retrospective study of adult ICU patients receiving meropenem via intravenous infusion.
- Therapeutic drug monitoring (TDM) used to measure meropenem trough concentrations (Cmin).
- UPLC-MS analysis of blood samples; logistic regression used to identify risk factors.
Main Results:
- 19.5% of patients (41/210) did not attain target meropenem concentrations.
- Multivariate analysis identified age, dosage, and augmented renal clearance (ARC) as predictors of non-attainment.
- Higher creatinine clearance correlated with an increased risk of sub-therapeutic meropenem levels.
Conclusions:
- Augmented renal clearance (ARC) is a significant predictor of meropenem target concentration non-attainment.
- Age and dosage also contribute to the risk of sub-therapeutic levels.
- Clinicians should consider ARC and creatinine clearance when dosing meropenem in critically ill patients to ensure efficacy.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Antimicrobial Effectiveness

